Viewing Study NCT05053659


Ignite Creation Date: 2025-12-24 @ 2:25 PM
Ignite Modification Date: 2026-04-16 @ 5:27 PM
Study NCT ID: NCT05053659
Status: RECRUITING
Last Update Posted: 2025-08-06
First Post: 2021-08-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Loncastuximab Tesirine and Venetoclax for Relapsed/ Refractory Non-Hodgkin Lymphoma
Sponsor: Paolo Caimi, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module